SpendRule

SpendRule, based in Dallas, US, delivers a contract intelligence platform that ensures compliance with service contract terms during payment, enhancing financial accuracy for healthcare organizations. Founded in 2025 in Dallas, US, SpendRule specializes in contract intelligence solutions tailored for healthcare providers. The company has successfully completed one deal, with its latest funding round occurring on February 17, 2026. This round raised USD 2.

00 mn, led by Abundant Venture Partners, with involvement from MemorialCare Innovation Fund and Zeal Capital Partners. SpendRule's founder has not been publicly detailed, nor are there mentions of subsidiaries or parent companies. SpendRule offers a contract intelligence platform designed to enforce purchased services contract terms at the point of payment. This innovative solution validates invoices against specific contract details prior to payment, effectively reducing the risk of overpayments within healthcare organizations.

Key functionalities include line-level validation against complex pricing structures, tier discounts, and value-added services, all powered by artificial intelligence. The end users of SpendRule's services primarily consist of hospitals and health systems across various geographical markets, including regions in the United States, where a significant volume of non-labor spend occurs in purchased services. The platform is tailored to solve critical issues related to invoice management, ensuring that healthcare providers can optimize their financial operations and uphold their margins without the burden of extensive manual audits. SpendRule's revenue model is based on subscription agreements and partnerships with healthcare institutions.

Hospitals subscribing to SpendRule’s services streamline their invoice validation process, reducing overpayment risks associated with purchased services. In these arrangements, healthcare providers pay a recurring fee for access to SpendRule’s AI-driven platform, which automates the invoice approval process and enhances operational efficiency. The company’s flagship offering is its contract intelligence platform, designed to provide real-time monitoring and validation of service invoices, allowing clients to avoid unnecessary costs and improve their financial outcomes directly, thereby enhancing overall revenue retention within the healthcare sector. In February 2026, SpendRule raised USD 2.

00 mn in venture funding, with plans to utilize this funding to expand its team and further develop its platform. The company aims to enhance its capabilities in helping hospitals track spending and validate invoices against contract terms before payment. Future product launches and enhancements are anticipated as SpendRule continues to evolve its offerings, targeting further penetration into healthcare markets, although specific geographic regions or timelines for these initiatives have not been disclosed.